DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Combining mortality and longitudinal measures in clinical trials.

Author(s): Finkelstein DM, Schoenfeld DA

Affiliation(s): Biostatistics Department, Harvard School of Public Health, Boston, MA 02115, USA. dfinkel@sdac.harvard.edu

Publication date & source: 1999-06-15, Stat Med., 18(11):1341-54.

Publication type: Clinical Trial; Randomized Controlled Trial

Clinical trials often assess therapeutic benefit on the basis of an event such as death or the diagnosis of disease. Usually, there are several additional longitudinal measures of clinical status which are collected to be used in the treatment comparison. This paper proposes a simple non-parametric test which combines a time to event measure and a longitudinal measure so that a substantial treatment difference on either of the measures will reject the null hypothesis. The test is applied on AIDS prophylaxis and paediatric trials.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017